SCHEMBL6824475

SCHEMBL6824475

CCCN(CCC)S(=O)(=O)c1ccc(C(=O)Nc2cc3ccccc3cc2C(=O)Nc2nccs2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
POLB P06746 2/20 0.58
GLA P06280 1/20 0.55
CA12 O43570 9/20 0.55
CA9 Q16790 9/20 0.55
CA1 P00915 6/20 0.55
ALDH1A1 P00352 3/20 0.53
HPGD P15428 2/20 0.53
LMNA P02545 1/20 0.53
GBA1 P04062 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
MAPK10 P53779 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
KDM4E B2RXH2 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6825234 0.82 CA9 (0.66) SMN1; SMN2CA12CA9CA1ALDH1A1
SCHEMBL6827172 0.80 CA12 (0.63) MEN1KMT2ASMN1; SMN2CA12CA9
SCHEMBL6821744 0.79 RAB9A (0.72) MEN1KMT2ASMN1; SMN2ALDH1A1HPGD
SCHEMBL6825144 0.79 CA9 (0.72) CA12CA9CA1ALDH1A1NPSR1
SCHEMBL6821696 0.79 CA9 (0.64) MEN1KMT2ASMN1; SMN2CA12CA9
SCHEMBL4816530 0.79 MEN1 (0.72) MEN1KMT2ASMN1; SMN2POLBGLA
SCHEMBL6821697 0.77 CA12 (0.61) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL6824885 0.77 CA9 (0.62) CA12CA9CA1ALDH1A1NPSR1
SCHEMBL6825568 0.76 RAB9A (0.67) MEN1KMT2ASMN1; SMN2POLBALDH1A1
SCHEMBL6825173 0.75 CA12 (0.60) MEN1KMT2APOLBCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004099127-A1 NOVEL COMPOUNDS AS KINASE INHIBITORS NOVO NORDISK A/S (DK) 2004-11-18 WO disclosed